Slow Churn Higher Or Another Pause For BLCM?

"Since August 21st, Bellicum’s stock has made a very strong rally on the back of news releases. The price of the biotech penny stock is up nearly over 30% since the beginning of the month. This gain and volume increase came initially following the company’s $140 million public offering on the 21st. Bellicum is also participating in 3 healthcare investor conferences throughout September."

Source: A List Of Penny Stocks To Watch As They Approach September Highs
pennystocks.com/penny-stocks-watch-list/2019/09/10/list-of-penny-stocks-to-watch-september-highs/

And I understand how speculation could play a role. However, there's less volume now compared to a few weeks ago and it's approaching a level that also falls in line with previous levels it was at before.
biotechbiotechnologybiotechstocksBLCMpennystocksStocksTrend Analysis

Also on:

Disclaimer